ECSP055802A - TIENO[3,2-b]PIRIDIN-6-CARBONITRILOS Y TIENO[2,3-b]PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINA CINASAS - Google Patents
TIENO[3,2-b]PIRIDIN-6-CARBONITRILOS Y TIENO[2,3-b]PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINA CINASASInfo
- Publication number
- ECSP055802A ECSP055802A EC2005005802A ECSP055802A ECSP055802A EC SP055802 A ECSP055802 A EC SP055802A EC 2005005802 A EC2005005802 A EC 2005005802A EC SP055802 A ECSP055802 A EC SP055802A EC SP055802 A ECSP055802 A EC SP055802A
- Authority
- EC
- Ecuador
- Prior art keywords
- carbonitrils
- piridin
- inhibitors
- protein kinases
- compounds
- Prior art date
Links
- 102000001253 Protein Kinase Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 108060006633 protein kinase Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000030761 polycystic kidney disease Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invención proporciona compuestos de las fórmulas (1a) - (1f), en donde: X, R1 y R2 se definen anteriormente en la especificación, los cuales son útiles en el tratamiento del cáncer, apoplejía, osteoporosis, enfermedad de riñón poliquístico, enfermedad autoinmune, artritis reumatoide y rechazo de transplantes y un procedimiento para producir los compuestos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42886202P | 2002-11-25 | 2002-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP055802A true ECSP055802A (es) | 2005-08-11 |
Family
ID=32393469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2005005802A ECSP055802A (es) | 2002-11-25 | 2005-05-19 | TIENO[3,2-b]PIRIDIN-6-CARBONITRILOS Y TIENO[2,3-b]PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINA CINASAS |
Country Status (20)
Country | Link |
---|---|
US (1) | US6987116B2 (es) |
EP (1) | EP1565474A2 (es) |
JP (1) | JP2006509760A (es) |
KR (1) | KR20050086770A (es) |
CN (1) | CN1714092A (es) |
AR (1) | AR042087A1 (es) |
AU (1) | AU2003290802A1 (es) |
BR (1) | BR0316534A (es) |
CA (1) | CA2502614A1 (es) |
CL (1) | CL2003002287A1 (es) |
EC (1) | ECSP055802A (es) |
MX (1) | MXPA05004744A (es) |
NI (1) | NI200500089A (es) |
NO (1) | NO20051928L (es) |
NZ (1) | NZ540104A (es) |
RU (1) | RU2005120018A (es) |
TW (1) | TW200412950A (es) |
UA (1) | UA81000C2 (es) |
WO (1) | WO2004048386A2 (es) |
ZA (1) | ZA200504238B (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7276519B2 (en) * | 2002-11-25 | 2007-10-02 | Wyeth | Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
FR2862647B1 (fr) | 2003-11-25 | 2008-07-04 | Aventis Pharma Sa | Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant |
US7772247B2 (en) * | 2004-07-30 | 2010-08-10 | Methylgene Inc. | Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptor |
GB0423653D0 (en) * | 2004-10-25 | 2004-11-24 | Piramed Ltd | Pharmaceutical compounds |
MX2007014616A (es) * | 2005-05-20 | 2009-08-12 | Methylgene Inc | Inhibidores de señalizacion del receptor del factor a de crecimiento endotelial vascular y del receptor del factor de crecimiento de hepatocitos. |
MX2007014617A (es) * | 2005-05-20 | 2008-02-11 | Methylgene Inc | Inhibidores de senalizacion de receptor de factor de crecimiento endotelial bascular y receptor de factor de crecimiento de hepatocitos. |
WO2007035428A1 (en) | 2005-09-15 | 2007-03-29 | Bristol-Myers Squibb Company | Met kinase inhibitors |
AR056200A1 (es) * | 2005-09-27 | 2007-09-26 | Wyeth Corp | Tieno [2,3-b]piridin-5-carbonitrilos como inhibidores de proteina quinasa |
US7547782B2 (en) | 2005-09-30 | 2009-06-16 | Bristol-Myers Squibb Company | Met kinase inhibitors |
JP2009526761A (ja) * | 2006-01-30 | 2009-07-23 | アレイ バイオファーマ、インコーポレイテッド | ヘテロ二環式チオフェン化合物および使用の方法 |
GB0601962D0 (en) * | 2006-01-31 | 2006-03-15 | Ucb Sa | Therapeutic agents |
US20100210596A1 (en) * | 2006-02-01 | 2010-08-19 | Bluestone Jeffrey A | Use of aminopyrimidine compounds in the treatment of immune disorders |
US20090099356A1 (en) * | 2006-02-08 | 2009-04-16 | Wyeth | Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction |
US20110053931A1 (en) * | 2006-06-08 | 2011-03-03 | John Gaudino | Quinoline compounds and methods of use |
ES2528797T3 (es) * | 2006-08-21 | 2015-02-12 | Genentech, Inc. | Compuestos de aza-benzotiofenilo y métodos de uso |
ATE531720T1 (de) * | 2006-08-21 | 2011-11-15 | Genentech Inc | Aza-benzofuranylverbindungen und anwendungsverfahren dafür |
TW200821318A (en) * | 2006-09-26 | 2008-05-16 | Wyeth Corp | Process for the preparation of 4-hydroxythieno[2,3-b]pyridine-5-carbonitriles |
GB0714384D0 (en) * | 2007-07-23 | 2007-09-05 | Ucb Pharma Sa | theraputic agents |
PL2183254T3 (pl) | 2007-08-29 | 2017-10-31 | Methylgene Inc | Inhibitory aktywności białkowej kinazy tyrozynowej |
US20090118276A1 (en) * | 2007-11-02 | 2009-05-07 | Wyeth | Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors |
WO2009093008A1 (en) * | 2008-01-21 | 2009-07-30 | Ucb Pharma S.A. | Thieno-pyridine derivatives as mek inhibitors |
AR070317A1 (es) * | 2008-02-06 | 2010-03-31 | Osi Pharm Inc | Furo (3,2-c) piridina y tieno (3,2-c) piridinas |
RU2498988C2 (ru) * | 2008-03-05 | 2013-11-20 | Метилджин, Инк. | Ингибиторы активности протеинтирозинкиназы |
GB0811304D0 (en) * | 2008-06-19 | 2008-07-30 | Ucb Pharma Sa | Therapeutic agents |
PE20110570A1 (es) * | 2008-07-01 | 2011-08-26 | Genentech Inc | Heterociclos biciclicos sustituidos |
TW201204733A (en) | 2010-06-25 | 2012-02-01 | Kowa Co | Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
WO2014004376A2 (en) | 2012-06-26 | 2014-01-03 | Del Mar Pharmaceuticals | Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof |
NZ710079A (en) | 2013-01-15 | 2020-01-31 | Incyte Holdings Corp | Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors |
KR101468207B1 (ko) * | 2013-02-14 | 2014-12-01 | 한국화학연구원 | 신규한 싸이에노[3,2-b]피리딜 우레아 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 유로텐신-Ⅱ 수용체 활성 관련 질환의 예방 또는 치료용 약학적 조성물 |
AR097431A1 (es) | 2013-08-23 | 2016-03-16 | Incyte Corp | Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de quinasas pim |
TWI734699B (zh) | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Pim激酶抑制劑之鹽 |
US9920032B2 (en) | 2015-10-02 | 2018-03-20 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
AR113922A1 (es) | 2017-12-08 | 2020-07-01 | Incyte Corp | Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas |
CN113195469B (zh) * | 2019-02-19 | 2024-05-24 | 四川科伦博泰生物医药股份有限公司 | 含氮并环化合物、其制备方法及用途 |
US11358971B2 (en) | 2019-07-03 | 2022-06-14 | H. Lundbeck A/S | Prodrugs of modulators of the NMDA receptor |
US11466027B2 (en) | 2019-07-03 | 2022-10-11 | H. Lundbeck A/S | Modulators of the NMDA receptor |
WO2021057256A1 (zh) * | 2019-09-29 | 2021-04-01 | 四川科伦博泰生物医药股份有限公司 | 一种含氮并环类化合物,包含其的药物组合物,其制备方法及其用途 |
EP4288054A1 (en) * | 2021-02-05 | 2023-12-13 | PTC Therapeutics, Inc. | Methods for treating spinocerebellar ataxia type 3 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US45A (en) * | 1836-10-11 | Machine fob shelling cokm | ||
EP0126970A3 (en) | 1983-04-27 | 1985-11-06 | Beecham Group Plc | Anxiolytic and anti-depressant thienopyridine derivatives |
AR004010A1 (es) * | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
HUP0100287A3 (en) * | 1997-11-11 | 2003-04-28 | Pfizer Prod Inc | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
CN1144786C (zh) * | 1998-09-29 | 2004-04-07 | 美国氰胺公司 | 作为蛋白质酪氨酸激酶抑制剂的取代的3-氰基喹啉 |
JP3270834B2 (ja) * | 1999-01-27 | 2002-04-02 | ファイザー・プロダクツ・インク | 抗がん剤として有用なヘテロ芳香族二環式誘導体 |
GB9906566D0 (en) * | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
ATE264328T1 (de) * | 1999-04-21 | 2004-04-15 | Wyeth Corp | Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen |
ATE353320T1 (de) * | 1999-12-29 | 2007-02-15 | Wyeth Corp | Tricyclische proteinkinasehemmer |
AR035851A1 (es) * | 2000-03-28 | 2004-07-21 | Wyeth Corp | 3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas |
ATE277933T1 (de) * | 2000-06-06 | 2004-10-15 | Pfizer Prod Inc | Thiophenverbindungen zur verwendung als antikrebsmittel |
US20020004511A1 (en) * | 2000-06-28 | 2002-01-10 | Luzzio Michael Joseph | Thiophene derivatives useful as anticancer agents |
US7253184B2 (en) * | 2000-11-02 | 2007-08-07 | Astrazeneca Ab | 4-Substituted quinolines as antitumor agents |
EP1418917A1 (en) | 2001-08-10 | 2004-05-19 | Novartis AG | Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
-
2003
- 2003-11-07 CL CL200302287A patent/CL2003002287A1/es unknown
- 2003-11-14 BR BR0316534-5A patent/BR0316534A/pt not_active IP Right Cessation
- 2003-11-14 JP JP2004555437A patent/JP2006509760A/ja active Pending
- 2003-11-14 WO PCT/US2003/036206 patent/WO2004048386A2/en active Application Filing
- 2003-11-14 RU RU2005120018/04A patent/RU2005120018A/ru not_active Application Discontinuation
- 2003-11-14 MX MXPA05004744A patent/MXPA05004744A/es active IP Right Grant
- 2003-11-14 EP EP03783385A patent/EP1565474A2/en not_active Withdrawn
- 2003-11-14 CA CA002502614A patent/CA2502614A1/en not_active Abandoned
- 2003-11-14 UA UAA200506270A patent/UA81000C2/uk unknown
- 2003-11-14 CN CNA2003801039013A patent/CN1714092A/zh active Pending
- 2003-11-14 NZ NZ540104A patent/NZ540104A/en unknown
- 2003-11-14 KR KR1020057009358A patent/KR20050086770A/ko not_active Application Discontinuation
- 2003-11-14 AU AU2003290802A patent/AU2003290802A1/en not_active Withdrawn
- 2003-11-17 TW TW092132143A patent/TW200412950A/zh unknown
- 2003-11-19 AR ARP030104277A patent/AR042087A1/es not_active Application Discontinuation
- 2003-11-21 US US10/719,359 patent/US6987116B2/en not_active Expired - Fee Related
-
2005
- 2005-04-20 NO NO20051928A patent/NO20051928L/no not_active Application Discontinuation
- 2005-04-26 NI NI200500089A patent/NI200500089A/es unknown
- 2005-05-19 EC EC2005005802A patent/ECSP055802A/es unknown
- 2005-05-24 ZA ZA200504238A patent/ZA200504238B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO20051928L (no) | 2005-08-19 |
US20040138251A1 (en) | 2004-07-15 |
CA2502614A1 (en) | 2004-06-10 |
NZ540104A (en) | 2007-05-31 |
WO2004048386A3 (en) | 2004-10-07 |
ZA200504238B (en) | 2009-09-30 |
CN1714092A (zh) | 2005-12-28 |
BR0316534A (pt) | 2005-10-04 |
RU2005120018A (ru) | 2006-05-10 |
NI200500089A (es) | 2006-01-11 |
KR20050086770A (ko) | 2005-08-30 |
UA81000C2 (en) | 2007-11-26 |
AR042087A1 (es) | 2005-06-08 |
TW200412950A (en) | 2004-08-01 |
WO2004048386A2 (en) | 2004-06-10 |
AU2003290802A1 (en) | 2004-06-18 |
CL2003002287A1 (es) | 2005-01-14 |
US6987116B2 (en) | 2006-01-17 |
EP1565474A2 (en) | 2005-08-24 |
NO20051928D0 (no) | 2005-04-20 |
WO2004048386A9 (en) | 2005-07-14 |
MXPA05004744A (es) | 2005-08-03 |
JP2006509760A (ja) | 2006-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI200500089A (es) | TIENO [3,2-b] PIRIDIN-6-CARBONITRILOS Y TIENO [2,3-b] PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINA CINASAS | |
ECSP067087A (es) | TIENO[3,2-b]PIRIDIN-6-CARBONITRILOS COMO INHIBIDORES DE LA QUINASA PROTEICA | |
CR8302A (es) | Compuestos heterociclicos fusionados | |
CR8074A (es) | Triazolopyrimidinas | |
PE20130012A1 (es) | Derivados de pirazol como inhibidores de jak | |
CY1117108T1 (el) | Ιμιδαζοτριαζινες και ιμιδαζοπυριμιδινες ως αναστολeiς κινασης | |
CR6736A (es) | 5-alquilpirido[2,3-d[ piridinas como inhibidores de tirosina kinasa | |
UY29458A1 (es) | Heterociclos sustituidos y usos de los mismos | |
UY27225A1 (es) | Inhibidores de la rho-quinasa | |
EA200701192A1 (ru) | Антагонисты toll-подобного рецептора 3, способы их получения и применение | |
PE20151336A1 (es) | Inhibidores de la tirosina-quinasa de bruton | |
BRPI0508622A (pt) | compostos de bifenil úteis como antagonistas do receptor muscarìnico | |
GT200300289A (es) | Derivados de pirrolopirimidina | |
ATE417051T1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
CL2012000917A1 (es) | Compuestos derivados de pirazolo [3,4-d] pirimidina, inhibidores btk; y uso en el tratamiento del cancer, enfermedades autoinmune, mastocitosis,osteoporosis,entre otras. | |
CR7235A (es) | Inhibidores beta- amino tetrahidroimidazol (1,2-a) pirazinas y tetrahidrotrioazolo (4,3-a) pirazinas como depetidil peptidasa para el tratamiento o prevencion de la diabetes | |
UY28404A1 (es) | Sal de isetionato de un inhibidor selectivo de cdk4 | |
ECSP045122A (es) | 3 - cianoquinolinas como inhibidores de quinasas egf-r y her2 | |
ECSP045255A (es) | Cumarinas utiles como biomarcadores | |
DK1601355T3 (da) | Diagnostisk metode til forudsigelse af nyretransplantationsafstödning | |
PA8658001A1 (es) | Sulfonamido-macrociclos y sus sales, una composicion farmaceutica que comprende estos compuestos, un metodo de preparacion y el uso de los mismos | |
DK2010544T3 (da) | Fremgangsmåde til fremstilling af Dorzolamid | |
EA200801404A1 (ru) | Новый способ получения 5-амино-3н-тиазоло[4,5-d]пиримидин-2-она | |
ATE397611T1 (de) | Verfahren zur herstellung von olanzapin | |
EA200401234A1 (ru) | Способ приготовления клопидогрела |